Because these types of stocks are less regulated than those listed on the national exchanges, a company trading OTC that seeks secondary funding sources would normally we a warning sign. Any investor should take a closer look into what the company attempts to achieve with the capital from the secondary funding sources. In this case, however, it appears based on the volume and recent insider buying that all signs lead to a healthy earnings report and continued growth that should, by all accounts, offset any dilution as a result of any additional shares offered through secondary funding (should this be the case).
What has become obvious is:
Profitability Analysis
"Although losing money on a net basis, IMTL is one of the more profitable companies in the Internet Software & Services industry. Its gross and operating margins are among the strongest of any peer while their net margin is above the industry median."
The book value of this stock is .02 as of today which is where it is trading. It appears if they cannot achieve the one million in additional cash from crowdfunding, they will have the ability to grow as planned without it: it may take a bit longer. I will post more information and provide explanations as time becomes available.
Disclaimer: I have a significant position in this stock. I am also unfamiliar with FINRA rules that govern OTC stocks. I am not affiliated with any market making firms, nor do I represent or own any websites that attempt to hype market conditions for OTC: BB stocks for the purpose of pumping and dumping them. I am just a curious investor trying to contribute to this thread.
God Bless,
Biff
